PEAK6 Group’s Dr. Reddy's Laboratories RDY Stock Holding History

PEAK6 Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,190	Closed	-$31K	–	4825
2017 Q4	$31K	Sell	4,190 -21,725	-84%	-$156K	﹤0.01%	3841
2017 Q3	$185K	Buy	+25,915	New	+$186K	﹤0.01%	3364
2017 Q1	–	Sell	-17,105	Closed	-$155K	–	4864
2016 Q4	$155K	Sell	17,105 -21,565	-56%	-$201K	﹤0.01%	3559
2016 Q3	$359K	Buy	+38,670	New	+$369K	﹤0.01%	2645
2016 Q2	–	Sell	-91,645	Closed	-$840K	–	4670
2016 Q1	$828K	Sell	91,645 -75,410	-45%	-$674K	0.01%	1847
2015 Q4	$1.55M	Buy	+167,055	New	+$1.83M	0.01%	1565
2015 Q3	–	Sell	-40,140	Closed	-$499K	–	5515
2015 Q2	$444K	Buy	+40,140	New	+$443K	﹤0.01%	2894
2014 Q4	–	Sell	-1,850	Closed	-$19K	–	5061
2014 Q3	$19K	Sell	1,850 -7,225	-80%	-$67.9K	﹤0.01%	4381
2014 Q2	$78K	Buy	+9,075	New	+$76.3K	﹤0.01%	3857
2013 Q4	–	Sell	-29,750	Closed	-$235K	–	5355
2013 Q3	$225K	Sell	29,750 -14,750	-33%	-$107K	﹤0.01%	3581
2013 Q2	$337K	Buy	+44,500	New	+$325K	﹤0.01%	3168

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PEAK6 Group's RDY Position: Q1 2018 in Review

PEAK6 Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2018, closing a stake of 4,190 shares — an estimated $31K sold.

PEAK6 Group first reported a position in RDY in Q2 2013 and held it in 11 quarters. The position peaked at $1.55M in Q4 2015. 121 funds tracked by Wall St. Rank hold RDY as of Q1 2018.

PEAK6 Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 4,190 Dr. Reddy's Laboratories shares in Q1 2018, an estimated $31K.
PEAK6 Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 11 quarters.
PEAK6 Group's Dr. Reddy's Laboratories position peaked at $1.55M in Q4 2015.
121 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.